wegovy glp-1 GLP-1s work but when they're stopped, the effects stop too: Expert Wegovy (Semaglutide) GLP-1 injection -

Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)

What sustained your weight at 35 may lead to weight gain at 45

Use of GLP-1 drugs for weight loss is common (as much as 12% of the population), but long-term adherence to the medications has been reported to be poor

However, an important shift is occurring Read More Oral GLP1 Therapy for Type 2 Diabetes: Why Pills Could Change the Playbook Jan 16, 2026 Articles, Blood Glucose Control, Diabetes, Obesity, Therapies, Top Articles, Type 2 Diabetes, Type 2 Diabetes 1,351 views The arrival of oral GLP1 therapy for type 2 diabetes marks a pivotal shift in diabetes care